首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.
【24h】

Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.

机译:癌症患者血液感染的来源和结局:中央静脉导管的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Simultaneously drawn quantitative blood cultures are used to diagnose catheter-related bloodstream infections. We conducted this study to determine the frequency with which central venous catheters were the source of bloodstream infections detected through paired positive blood cultures drawn from cancer patients and the potential for quantitative blood cultures to help predict outcome in neutropenic and non-neutropenic patients. From September 1999 to November 2000, we identified 169 patients with bloodstream infections. Of all bloodstream infections, 56% were catheter-related bloodstream infections. Gram-positive bacteremia was found to be catheter-related in 55% and 69% of patients with hematologic malignancy and solid tumors, respectively, whereas gram-negative bacteremia was catheter-related in only 19% of patients with underlying hematologic malignancy and in 60% of patients with solid tumor (P = 0.01). By multivariate analysis, poor response was associated with critical illness and persistent neutropenia (P < 0.01). In neutropenic patients with catheter-related bloodstream infections, peripheral quantitative blood cultures of >or=100 CFU/mL was also associated with poor response (P = 0.05). Central venous catheters were the major source of bloodstream infection, particularly in patients with solid tumors. In addition to critical illness and persistent neutropenia, quantitative blood cultures might be useful in predicting outcomes for neutropenic patients with catheter-related bloodstream infections.
机译:同时抽取定量的血培养物用于诊断导管相关的血流感染。我们进行了这项研究,以确定通过从癌症患者中抽取成对的阳性血液培养物检测到中心静脉导管是血流感染源的频率,以及定量血液培养物的潜力,以帮助预测中性粒细胞减少和非中性粒细胞减少患者的结局。从1999年9月至2000年11月,我们确定了169例血液感染患者。在所有的血液感染中,有56%是导管相关的血液感染。发现革兰氏阳性菌血症分别与55%和69%的血液系统恶性肿瘤和实体瘤患者相关,而革兰氏阴性菌血症仅与19%的潜在血液系统恶性肿瘤患者和导管相关。实体瘤患者的百分比(P = 0.01)。通过多变量分析,不良反应与危重病和持续中性粒细胞减少有关(P <0.01)。在患有与导管相关的血流感染的中性粒细胞减少患者中,外周定量血液培养物≥100 CFU / mL也与不良反应相关(P = 0.05)。中央静脉导管是血液感染的主要来源,特别是在实体瘤患者中。除了重病和持续性中性粒细胞减少症,定量的血培养可能有助于预测患有导管相关性血流感染的中性粒细胞减少症患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号